Earnings · China A-shares
Guhan Pharmaceutical Group Co., Ltd. Class A (000590) earnings
Guhan Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -60.69% year on year, -37.49% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -2.99% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -60.69%
- Excl. one-offs YoY
- -37.49%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.61% | — |
| 3 days | -2.99% | — |
| 7 days | -4.61% | — |
| 14 days | -7.85% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 2 of 8 reports (average -0.88%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | -¥23.82M | -60.69% | -37.49% | -2.10% | -0.10 | -4.45% | -2.99% | — | — |
| 2026 interim report | 2026-08-27 | -¥14.97M | +12.82% | +24.29% | -5.80% | -0.06 | -2.77% | -0.42% | -8.88% | +0.05% |
| 2026 Q1 report | 2026-04-28 | -¥6.81M | +58.09% | +55.95% | +9.89% | -0.03 | -1.25% | +0.72% | -15.97% | -15.35% |
| 2025 annual report | 2026-03-31 | -¥50.52M | +59.74% | +63.41% | -1.61% | -0.21 | -8.82% | -0.08% | -12.69% | -21.11% |
| 2025 Q3 report | 2025-10-30 | -¥14.82M | +47.91% | +35.13% | +3.97% | -0.06 | -2.51% | -1.06% | -7.99% | -3.25% |
| 2025 interim report | 2025-08-27 | -¥17.17M | +26.61% | +7.12% | -2.87% | -0.07 | -2.91% | -4.36% | -9.45% | -13.23% |
| 2025 Q1 report | 2025-04-28 | -¥16.26M | -96.23% | -82.58% | -15.40% | -0.07 | -2.75% | -2.46% | +7.61% | +4.37% |
| 2024 annual report | 2025-03-28 | -¥125.47M | -596.98% | — | -15.18% | -0.52 | -18.98% | +3.61% | +4.78% | +5.87% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.